Search

Cell-Free Mixing of Escherichia coli Crude Extracts to Prototype and Rationally Engineer High-Titer Mevalonate Synthesis

메타 데이터

바이오화학분류
    • 바이오플라스틱
      1. 고무
      2. 플라스틱
    • 바이오정밀화학
      1. 용매
      2. 화학제품
      3. 연료
      4. 기타
    • 화장품용 기능성소재
      1. 계면활성제⁄증점제
    • 의료용 화학소재
      1. 치료제
      2. 건강보조식품
      3. 식품첨가제
논문

Cell-Free Mixing of Escherichia coli Crude Extracts to Prototype and Rationally Engineer High-Titer Mevalonate Synthesis

학술지

ACS Synthetic biology

저자명

Dudley, Quentin M.; Anderson, Kim C.; Jewett, Michael C.

초록

<P>Cell-free metabolic engineering (CFME) is advancing a powerful paradigm for accelerating the design and synthesis of biosynthetic pathways. However, as most cell-free biomolecule synthesis systems to date use purified enzymes, energy and cofactor balance can be limiting. To address this challenge, we report a new CFME framework for building biosynthetic pathways by mixing multiple crude lysates, or extracts. In our modular approach, cell-free lysates, each selectively enriched with an overexpressed enzyme, are generated in parallel and then combinatorically mixed to construct a full biosynthetic pathway. Endogenous enzymes in the cell-free extract fuel high-level energy and cofactor regeneration. As a model, we apply our framework to synthesize mevalonate, an intermediate in isoprenoid synthesis. We use our approach to rapidly screen enzyme variants, optimize enzyme ratios, and explore cofactor landscapes for improving pathway performance. Further, we show that genomic deletions in the source strain redirect metabolic flux in resultant lysates. In an optimized system, mevalonate was synthesized at 17.6 g&middot;L<SUP>&ndash;1</SUP> (119 mM) over 20 h, resulting in a volumetric productivity of 0.88 g&middot;L<SUP>&ndash;1</SUP>&middot;hr<SUP>&ndash;1</SUP>. We also demonstrate that this system can be lyophilized and retain biosynthesis capability. Our system catalyzes &sim;1250 turnover events for the cofactor NAD<SUP>+</SUP> and demonstrates the ability to rapidly prototype and debug enzymatic pathways <I>in vitro</I> for compelling metabolic engineering and synthetic biology applications.</P><P><B>Graphic Abstract</B><BR><IMG SRC='http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/asbcd6/2016/asbcd6.2016.5.issue-12/acssynbio.6b00154/production/images/medium/sb-2016-00154p_0007.gif'></P><P><A href='http://pubs.acs.org/doi/suppl/10.1021/sb6b00154'>ACS Electronic Supporting Info</A></P>

발행연도

2016

발행기관

American Chemical Society

ISSN

2161-5063

5

12

페이지

pp.1578-1588

주제어

cell-free metabolic engineering; metabolic pathway debugging; cell-free synthetic biology; mevalonate; Escherichia coli; in vitro

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

논문; 2016-12-31

Export

About

Search

Trend